(HealthDay News) — Venous thromboembolism (VTE) risk varies across hormonal contraceptives, according to a research letter published online Feb. 10 in the Journal of the American Medical Association.

which studied datasets and uncovered indications that specifically type I protein S deficiency is linked to venous thromboembolism. “That was a nice, exciting way of being able to look at how we ...

The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...

Denmark: A recent study published in the Journal of the American Medical Association (JAMA) has shed light on the varying ...

(MENAFN- EIN Presswire) Leading companies such as LEO Pharma, Sanofi, Daiichi Sankyo Inc, are driving advancements in Venous Thromboembolism treatments to enhance patient care. LAS VEGAS , NV ...

The following is a summary of “Association of Sleep Traits With Venous Thromboembolism: Prospective Cohort and Mendelian Randomization Studies,” published in the January 2025 issue of Hematology by Li ...

TAT and several other markers demonstrated an ability to predict the development of venous thromboembolism in patients with cervical cancer.